Viridian Therapeutics, Inc.\DE Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Viridian Therapeutics, Inc.\DE quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Viridian Therapeutics, Inc.\DE Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 79.2M shares, a 81.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 79.2M +35.5M +81.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 63.9M +20.3M +46.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 63.8M +20.7M +48.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54M +12.7M +30.7% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 43.7M +3.46M +8.59% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 43.6M +15.1M +53% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 43.1M +19.1M +80% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 41.3M +17.4M +72.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 40.2M +20.9M +108% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 28.5M +19.9M +231% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 23.9M +16.7M +231% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 23.9M +19.7M +465% Dec 31, 2021 10-K 2023-03-09
Q3 2021 19.4M -37.7M -66.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 8.61M -44.5M -83.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 7.23M -45.8M -86.4% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 4.23M +1.91M +82.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 57.1M +25.9M +83% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 53.1M +22M +71% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 53.1M +22.2M +71.7% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 2.32M -28.5M -92.5% Dec 31, 2019 10-K 2021-03-26
Q3 2019 31.2M +348K +1.13% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 31M +442K +1.44% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 30.9M +735K +2.43% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 30.8M +8.27M +36.7% Dec 31, 2018 10-K 2020-03-13
Q3 2018 30.8M +8.95M +40.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 30.6M +9.11M +42.4% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 30.2M +8.78M +41% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 22.6M +21.7M +2607% Dec 31, 2017 10-K 2019-03-14
Q3 2017 21.9M +11.1M +103% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 21.5M +10.7M +99.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 21.4M +10.7M +99.8% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 834K +125K +17.6% Dec 31, 2016 10-K 2018-03-15
Q3 2016 10.8M +155K +1.46% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 10.8M +2.93M +37.4% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 10.7M +3.2M +42.7% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 709K -3.07M -81.3% Dec 31, 2015 10-K 2017-03-24
Q3 2015 10.6M +6.85M +181% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 7.85M +4.06M +107% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 7.5M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 3.78M +3.78M Dec 31, 2014 10-K 2016-03-21
Q3 2014 3.78M Sep 30, 2014 10-Q 2014-11-14
Q2 2014 3.78M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 0 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.